# US 2016/0250382 A1 · Resorbable, amino acid-based poly(ester urea)s scaffold for vascular graft tissue engineering

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0250382 A1
- Document ID: US20160250382A1
- Status: Published application
- Kind: A1
- Application number: 15/032,809
- Filed: 2014-10-29
- Published: 2016-09-01
- Earliest claimed: 2013-10-29
- Assignees: The University of Akron
- Inventors: Matthew Becker; Darrell Reneker; Yaohua Gao
- Web page: https://patentgrep.com/patent/US20160250382A1

## CPC

- A61L 27/18: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- A61F 2/07: Stent-grafts
- A61F 2/82: Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents (stent-grafts for tubular structures of the body other than blood vessels A61F2/04; stent-grafts for blood vessels A61F2/07)
- A61L 27/507: {for artificial blood vessels (apparatus for applying cells on a blood vessel prosthesis A61F2/062)}
- A61L 27/58: Materials at least partially resorbable by the body
- C08G 69/10: Alpha-amino-carboxylic acids {(polysuccinimides C08G73/1092)}
- C08G 69/44: Polyester-amides
- C08G 71/00: Macromolecular compounds obtained by reactions forming a ureide or urethane link, otherwise, than from isocyanate radicals in the main chain of the macromolecule
- C08G 71/02: Polyureas
- C09D 175/02: Polyureas
- D01D 5/003: {the material being a polymer solution or dispersion (D01D5/0053 takes precedence)}
- D01F 6/68: from polyaminoacids or polypeptides
- D01F 6/84: from copolyesters
- A61F 2/06: Blood vessels
- A61F 2210/0004: bioabsorbable
- A61F 2230/0069: cylindrical
- A61F 2240/001: Designing or manufacturing processes
- A61L 2400/12: Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
- C08G 2230/00: Compositions for preparing biodegradable polymers
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- C08G: MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C09D: COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR (cosmetics A61K; processes for applying liquids or other fluent materials to surfaces, in general, B05D; staining wood B27K5/02; glazes or vitreous enamels C03C; natural resins, French polish, drying-oils, driers, turpentine, per se, C09F; polishing compositions other than French polish, ski waxes C09G; adhesives or use of materials as adhesives C09J; materials for sealing or packing joints or covers C09K3/10; materials for stopping leaks C09K3/12; processes for the electrolytic or electrophoretic production of coatings C25D)
- D01D: MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01F: CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS

## Abstract

Embodiments relate to amino acid-based poly(ester urea)s with amino acid residues selected L-leucine, L-isoleucine, L-valine or combinations thereof. The amino acid-based poly(ester urea)S may optionally include a second amino acid residue selected from proteinogenic amino acids and non-proteinogenic amino acids. The amino acid-based poly(ester urea)s are particular useful for the preparation of vascular grafts. Due to the biocompatibility of the amino acid-based poly(ester urea)s, vascular grafts prepared from amino acid-based poly(ester urea)s with small internal diameters (i.e. less than 5 mm) may be prepared and inserted into a patient or animal, and provide a substantial decrease in the risk of failure compared to conventional polymers used in vascular grafts.

## Claims

### Claim 1

An amino acid-based poly(ester urea) comprising
an amino acid residue selected from L-leucine, L-isoleucine, L-valine or combinations thereof; and
a hydrocarbylene group having from 10 to 12 carbon atoms;
where the hydrocarbylene group is attached to the amino acid residue through an ester group.

### Claim 2 (depends on 1)

The amino acid-based poly(ester urea) of claim 1, where the amino acid-based poly(ester urea) further includes a second amino acid residue selected from proteinogenic amino acids and non-proteinogenic amino acids.

### Claim 3 (depends on 2)

The amino acid-based poly(ester urea) of claim 2, where the second amino acid residue is defined by the formula:
where R is a pendent functional group.

### Claim 4 (depends on 3)

The amino acid-based poly(ester urea) of claim 3, where the pendent functional group is an oxygen atom connected to a alkyl or aryl group containing an alkyne group, an alkene group, an azide group, a benzyl protected phenol group, a ketone group or a strained cyclooctyne.

### Claim 5 (depends on 1)

The amino acid-based poly(ester urea) of claim 1, where the amino acid-based poly(ester urea) comprises the following formula:
where each J is individually a L-leucine, L-isoleucine, or L-valine side chain, n is about 10 to 12 units, and m is about 10 to 500 units.

### Claim 6

(canceled)

### Claim 7 (depends on 5)

The amino acid-based poly(ester urea) of claim 5, where the amino acid-based poly(ester urea) comprises the following formula:
where n is about 12 to 12 units, and m is about 10 to 500 units.

### Claim 8 (depends on 1)

The amino acid-based poly(ester urea) of claim 1, where the amino acid-based poly(ester urea) comprises the following formula:
where n is about 10 to 12 units, and m is about 10 to 500 units.

### Claim 9 (depends on 1)

The amino acid-based poly(ester urea) of claim 1, where the amino acid-based poly(ester urea) comprises the following formula:
where n is about 10 to 12 units, and m is about 10 to 500 units.

### Claim 10 (depends on 1)

The amino acid-based poly(ester urea) of claim 1, where the amino acid-based poly(ester urea) comprises the following formula:
where each X1 is individually an L-leucine, L-isoleucine, L-valine, proteinogenic amino acids or non-proteinogenic amino acid side chain with the proviso that at least one X1 is selected from-L-leucine, L-isoleucine, and L-valine, n is 1 to about 20 units, and m is about 10 to 500 units

### Claim 11 (depends on 1)

The amino acid-based poly(ester urea) of claim 1, where the amino acid-based poly(ester urea) comprises the following formula:
where each J is individually a L-leucine, L-isoleucine, or L-valine side chain, each X2 is individually a proteinogenic amino acids or non-proteinogenic amino acid side chain, each n is individually about 10 to 12 units, and each m is individually about 10 to 500 units

### Claim 12 (depends on 10)

The amino acid-based poly(ester urea) of claim 10, where one or more of the X1 groups is a proteinogenic amino acids or non-proteinogenic amino acid side chain defined by the formula
where R is a pendent functional group.

### Claim 13

An amino acid-based poly(ester urea) vascular graft comprising a tubular structure comprising an amino acid-based poly(ester urea) with amino acid residues selected from L-leucine, L-isoleucine, L-Valine or combinations thereof.

### Claim 14 (depends on 13)

The poly(ester urea) vascular graft of claim 13, where the amino acid-based poly(ester urea) is defined by the following formula:
where each J is individually a L-leucine, L-isoleucine, or L-valine side chain, n is about 10 to 23 units, and m is about 10 to 500 units.

### Claim 15 (depends on 13)

The poly(ester urea) vascular graft of claim 13, where the amino acid-based poly(ester urea) is defined by the following formula:
where each X1 is individually an L-leucine, L-isoleucine, L-valine, proteinogenic amino acid or non-proteinogenic amino acid side chain with the proviso that at least one X1 is selected from L-leucine, L-isoleucine, and L-valine, n is 10 to about 12 units, and m is about 10 to 500 units

### Claim 16 (depends on 13)

The poly(ester urea) vascular graft of claim 13, where the poly(ester urea) is electrospun.

### Claim 17 (depends on 13)

The poly(ester urea) vascular graft of claim 13, where the vascular graft has an internal diameter of about 0.05 mm to about 20 mm.

### Claim 18

(canceled)

### Claim 19

(canceled)

### Claim 20

(canceled)

### Claim 21

A method of preparing an amino acid-based poly(ester urea) vascular graft comprising
(i) providing a charged solution of amino acid-based poly(ester urea) with amino acid residues selected L-leucine, L-isoleucine, L-valine or combinations thereof;
(ii) providing a grounded mandrel coated with a dissolvable coating;
(iii) electrospinning the poly(ester urea) onto the dissolvable coating of the grounded mandrel to produce a tubular structure,
(iv) dissolving the dissolvable coating; and
(v) removing the tubular structure from the mandrel.

### Claim 22 (depends on 21)

The method of claim 21, where the amino acid-based poly(ester urea) defined by the following formula:
where each J is individually a L-leucine, L-isoleucine, or L-Valine side chain, n is about 10 to 12 units, and m is about 10 to 500 units.

### Claim 23 (depends on 21)

The method of claim 21, where the amino acid-based poly(ester urea) defined by the following formula
where each X1 is individually an L-leucine, L-isoleucine, L-valine, proteinogenic amino acids or non-proteinogenic amino acid side chain with the proviso that at least one X1 is selected from L-leucine, L-isoleucine, and L-valine, n is 10 to about 12 units, and m is about 10 to 500 units

### Claim 24

(canceled)

### Claim 25 (depends on 21)

The method of claim 21, where the dissolvable coating is a water soluble sugar.

### Claim 26

(canceled)

### Claim 27

(canceled)

### Claim 28

An amino acid-based poly(ester urea) preparable by
(i) reacting amino acids with a diol to produce an amino acid-based monomer, where the amino acids are selected from L-leucine, L-isoleucine, L-valine, proteinogenic amino acids, non-proteinogenic amino acids, and a combination thereof, with the proviso that at least one amino acid is selected from L-leucine, L-isoleucine, and L-valine; and
(ii) reacting the amino acid-based monomer with a phosgene or triphosgene to produce an amino acid-based poly(ester urea);
where the diol is selected from decane-1,10-diol, undecane-1,11-diol, and dodecane-1,12-diol.

### Claim 29

(canceled)

### Claim 30

(canceled)

### Claim 31

(canceled)
